8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors100 citations

Molecular Mechanism of Malignant Transformation of Balb/c-3T3 Cells Induced by Long-Term Exposure to 1800 MHz Radiofrequency Electromagnetic Radiation (RF-EMR)

Bioeffects Seen

Ding Z, Xiang X, Li J, Wu S · 2022

Share:

Long-term exposure to 1800 MHz RF-EMR at 8.0 W/kg induced malignant transformation in cultured cells through alterations in lipid metabolic pathways, suggesting a potential mechanism for RF-EMR carcinogenic effects.

Plain English Summary

Summary written for general audiences

This study exposed mouse Balb/c-3T3 cells to 1800 MHz radiofrequency electromagnetic radiation for 40-60 days and observed signs of malignant transformation, including increased cell proliferation, migration, visible foci formation, and tumor development when transplanted into SCID mice. The researchers identified lipid metabolism and the mevalonate pathway as key biological processes involved in the observed cellular changes.

Why This Matters

This is an in vitro cell transformation study using established mouse fibroblast cells, which provides mechanistic data but requires confirmation through additional in vivo studies and epidemiological evidence to establish relevance to human health. The specific identification of the mevalonate pathway offers a testable hypothesis for understanding potential biological mechanisms of RF exposure.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Ding Z, Xiang X, Li J, Wu S (2022). Molecular Mechanism of Malignant Transformation of Balb/c-3T3 Cells Induced by Long-Term Exposure to 1800 MHz Radiofrequency Electromagnetic Radiation (RF-EMR).
Show BibTeX
@article{ding_z_xiang_x_li_j_wu_s_ce2746,
  author = {Ding Z and Xiang X and Li J and Wu S},
  title = {Molecular Mechanism of Malignant Transformation of Balb/c-3T3 Cells Induced by Long-Term Exposure to 1800 MHz Radiofrequency Electromagnetic Radiation (RF-EMR)},
  year = {2022},
  doi = {10.1038/s41467-022-29577-x},
  
}
DOI: 10.1038/s41467-022-29577-xPubMed: 35200397

Quick Questions About This Study

NNMT (Nicotinamide N-methyltransferase) is a metabolic enzyme that the study identified as promoting kidney cancer growth. It modifies DNA repair proteins through a process called homocysteinylation, making cancer cells more efficient at repairing DNA damage and surviving cellular stress.
The proteogenomic analysis classified clear cell renal cell carcinoma into three distinct subtypes (GP1-3). The most aggressive subtype, GP1, showed the strongest immune response, highest metastasis rates, and greatest metabolic imbalance among the 232 patients studied.
Yes, cancer cells with enhanced DNA repair mechanisms can survive treatments that rely on causing DNA damage. The study found that NNMT-driven DNA repair improvements help aggressive kidney cancers resist cellular stress and continue growing, making them harder to treat.
GP1 subtype exhibits the most aggressive characteristics including strongest immune phenotype, increased metastasis potential, and severe metabolic imbalance. These features were linked to worse clinical outcomes, making GP1 the deadliest of the three identified kidney cancer subtypes.
Homocysteinylation is a chemical modification that NNMT causes to DNA-PKcs, a key DNA repair protein. This modification increases the protein's repair efficiency, allowing cancer cells to fix DNA damage more effectively and survive conditions that would normally kill them.